SANAHEAL, INC.

Hemostatic Bioadhesive Paste for Coagulation-Independent Rapid Control of Bleeding

Based based in Somerville, MA, SANAHEAL, INC. works in national heart lung and blood institute, founded in 2021.

Profile

ABSTRACT
The objective of this proposal is to optimize and validate the hemostatic bioadhesive paste in compliance with
FDA regulatory guidance for the FDA IDE approval in advance of the future pivotal clinical trial and ultimate
regulatory clearance and commercialization. In light of the huge and rapidly growing clinical and economic costs
of major hemorrhagic events in cardiovascular and other surgeries, various hemostatic agents have been
developed and clinically tested. To date, however, there is no hemostatic solution that can achieve effective and
rapid hemostasis in frequent and high-risk bleeding of patients under anticoagulation or coagulopathic settings
due to the incompatibility of conventional coagulation-based hemostatic approaches. To address these
limitations of existing solutions, during the prior development (Phase I-equivalent), our collaborative team
developed a proof-of-concept prototype of a hemostatic bioadhesive paste for rapid (within 10 s) coagulation-
independent control of bleedings by uniquely utilizing the novel blood-resistant bioadhesive mechanism. The
preliminary pre-clinical validation and analysis based on in vivo rat and porcine models demonstrated the
promising hemostatic efficacy and underlying mechanism of the hemostatic bioadhesive paste for the
bioadhesion-based coagulation-independent rapid control of bleedings. Building upon the promisi

As a business in national heart lung and blood institute, SANAHEAL, INC. is listed here with the public details available about it.

Somerville, MA is where the company is located.

Directory data places it at the SBIR/STTR stage.

The company reports a headcount in the 1-10 range.

Public records show total funding of about $1.2M.

Website: sanaheal.com